Three scientists were recognized by the Lasker Awards for their work on the GLP-1 hormone. Others were honored for work to stop H.I.V. and for immune system discoveries.

GLP-1 based drugs are transforming the treatment of obesity and opening up new avenues for addressing heart disease, addiction, and even Alzheimer’s. Now, three scientists who played key roles in their invention have won a prestigious Lasker Award for biomedical research.

Three scientists are honored for developing a class of blockbuster weight-loss drugs. Is a Nobel prize on the way?

Each year, the Lasker Awards honor a number of medical professionals doing standout work in research and public service. The New York Times has called the awards “the nation’s most prestigious medical prizes.

One of the researchers described the circumstances that led to the discovery as “serendipity.” This year’s prestigious Lasker medical awards recognize a trio of scientists without whom Ozempic and other blockbuster weight-loss drugs might not exist.

The immune system has a remarkable way of fighting foreign invaders. Antibodies circulating in the blood can latch on to bits of virus, and certain cells can gobble up bacteria. But when wayward DNA gets inside our cells,